Psilocybin has been shown to improve symptoms of depression , anxiety , and major depressive disorder. Many physicians, advanced practice practitioners, and nurses experienced depression, burnout , and posttraumatic stress disorder (PTSD) during the COVID-19 pandemic. A recent study has examined whether psilocybin could improve symptoms of depression, burnout, and PTSD in 30 clinicians who developed these conditions while providing frontline care during the pandemic. In the study, psilocybin significantly reduced symptoms of depression in clinicians at 28 days compared to the niacin group (depression score: -21.3 vs.
-9.3). While psilocybin also reduced burnout symptoms, the difference compared to the niacin group was not statistically significant (burnout score: -6.4 vs. -2.3). Additionally, psilocybin showed a notable reduction in PTSD symptoms compared to niacin (PTSD score: -16.7…
